A new wave of scientific understanding is placing ferroptosis, a distinct form of iron-dependent cell death, at the forefront of efforts to overcome drug resistance in digestive cancers. These cancers ...

NSCLC showed the largest reduction in metastatic progression with GLP-1RAs versus gliptins (HR 0.50), with significant ...

Two KRAS-targeted strategies are starting to reshape treatment for metastatic pancreatic cancer after decades of limited progress with chemotherapy.

The discovery challenges the long-standing idea that early humans mainly evolved and survived in open grasslands, coasts, or ...

UH engineers helped develop an mRNA-based strategy that boosts cancer-fighting T cells and, in mouse studies, helped ...

Using artificial intelligence (AI) to specialize treatment for patients with different kinds of cancer can be a boon to clinicians looking to personalize their care. Pathways have become critical in ...

Why do two people with the same cancer diagnosis—the same stage, the same cell type, and the same clinical profile—often have ...

Dynamic clinical pathways are essential to keep pace with rapid advancements in oncology treatments and FDA approvals. Inclusive participation and effective communication are vital for pathway ...

SEATTLE — Since 2005, Cancer Pathways has been going into as many school classrooms to share life-saving information. Cancer Pathways, formerly Gilda's Club Seattle, has made it a goal to reach as ...